JO1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - John B Sanfilippo & Son Inc

Watchlist Manager

Watchlist

Price: 60 EUR Market Closed

Market Cap: €691.6m

J	John B Sanfilippo & Son Inc XBER:JO1	US
	Lyell Immunopharma Inc NASDAQ:LYEL	US

Profitability Summary

John B Sanfilippo & Son Inc's profitability score is 52/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

19%

Sustainable 3Y Average Gross Margin

20%

Declining Gross Margin

21% > 19%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

9% > 8%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

6% > 6%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

10% > 4%

Positive ROE

19%

Positive 3Y Average ROE

Positive 3Y Average ROIC

15%

Declining ROIC

17% > 14%

View All

Hide

Collapse

52 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.